Healthcare
M&A Advisory
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Opiant Pharmaceuticals. United Kingdom, United States. Announced Date 14/11/2022. Closed Date 02/03/2023. Deal value: $145m. Indivior to acquire Opiant Pharmaceuticals. Industry: Opiant Pharmaceuticals is a specialty pharmaceutical company focused on developing treatments for substance use and eating disorders.